FDA offers draft guidance for registries as RWD
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy